Health Care & Life Sciences » Pharmaceuticals | Bharat Immunologicals & Biologicals Corp. Ltd.

Bharat Immunologicals & Biologicals Corp. Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
2,028
1,462
1,280
1,242
348
836
Cost of Goods Sold (COGS) incl. D&A
1,821
1,370
1,298
1,102
403
829
Gross Income
207
92
18
140
55
7
SG&A Expense
100
54
34
18
34
99
EBIT
131
38
52
122
89
92
Unusual Expense
-
1
1
1
-
-
Non Operating Income/Expense
13
12
23
5
15
26
Interest Expense
13
11
27
32
5
15
Pretax Income
110
21
90
95
79
81
Income Tax
46
5
27
27
27
25
Consolidated Net Income
64
15
62
67
52
56
Net Income
64
15
62
67
52
56
Net Income After Extraordinaries
64
15
62
67
52
56
Net Income Available to Common
64
15
62
67
52
56
EPS (Basic)
1.48
0.36
1.44
1.56
1.20
1.29
Basic Shares Outstanding
43
43
43
43
-
-
EPS (Diluted)
1.48
0.36
1.44
1.56
-
-
Diluted Shares Outstanding
43
43
43
43
-
-
EBITDA
142
47
45
128
85
89
Other Operating Expense
-
-
25
-
-
-
Non-Operating Interest Income
4
6
13
9
-
-

About Bharat Immunologicals & Biologicals Corp.

View Profile
Address
OPV Plant
Bulandshahr Uttar Pradesh 203203
India
Employees -
Website http://www.bibcol.com
Updated 07/08/2019
Bharat Immunologicals & Biologicals Corp. Ltd. engages in the manufacture and market of pharmaceutical products. It operates through the Oral Polio Vaccine and Zinc Tablets business segments. It also offers diarrhea management kit for young children and iron deficiency anemia tablets.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.